Erschienen in:
29.06.2020 | COVID-19 | Correspondence
Zur Zeit gratis
Repurposed GI Drugs in the Treatment of COVID-19
verfasst von:
Enrik John T. Aguila, Ian Homer Y. Cua
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 8/2020
Einloggen, um Zugang zu erhalten
Excerpt
We read with great interest the review article authored by Dr. Kopel and colleagues. Their study discussed on different therapies that are being investigated for the treatment of COVID-19 [
1]. Recently, there have been studies regarding antisecretory agents as repurposed drugs. We would like to highlight the evidence of these common GI drugs and their potentials in the treatment of COVID-19. …